A 51-year-old man presented to the author\'s department with retrosternal discomfort. Esophagogastroduodenoscopy revealed longitudinal sloughing of mucosal casts in the mid and lower esophagus ([Picture](#g001){ref-type="fig"}). *Candida* species were not detected by a microscopic examination. Although he had never taken dabigatran, the endoscopic findings were compatible with chemical esophagitis. Detailed inquiries confirmed that he had taken celecoxib (200 mg/day) due to gout for seven days without drinking sufficient water; thus, celecoxib therapy was discontinued, and rabeprazole (10 mg/day) was administered. The symptoms disappeared within a few days. One month later, follow-up endoscopy showed complete healing of the esophageal lesions.
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Non-steroidal anti-inflammatory drugs are one of the most common causes of drug-induced esophagitis ([@B1]). Celecoxib, a highly selective cyclooxygenase-2 inhibitor, was developed to reduce gastrointestinal toxicity; however, cases of severe desquamative esophagitis have been reported in patients treated with celecoxib ([@B2]). The pathogenesis may include local chemical effects caused by the absorption of the lipid-soluble drug by the esophageal mucosa, especially at low pH ([@B2]).
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